Neuralink Raises $600M: Elon Musk's Neurotech Company Valued at $9 Billion

Neuralink Secures $600 Million Funding

Neuralink, the brain implant venture founded by Elon Musk, has successfully completed a funding round of $600 million. This new investment establishes a pre-money valuation for the company at $9 billion, according to a report by Semafor.

Details of the Funding Round

The identities of the investors participating in this latest funding round have not yet been disclosed by Semafor. Previously, Neuralink secured $43 million in venture capital funding in November 2023.

In June 2023, the company’s valuation was approximately $5 billion, as reported by Reuters. This represents significant growth in a relatively short period.

Company Response and Prior Reports

Requests for official comment from Neuralink made outside of standard business hours have not yet been addressed. The company has not publicly confirmed the funding details.

Semafor’s reporting aligns with earlier information published by Bloomberg in April. Bloomberg indicated that Neuralink was aiming to raise $500 million, with a targeted pre-money valuation of $8.5 billion.

Regulatory Approval and Patient Progress

Neuralink received “breakthrough device” designation from the U.S. Food and Drug Administration (FDA) last year. This clearance facilitated the advancement of their technology.

To date, three individuals have received Neuralink implants. Recently, a patient with limited verbal communication demonstrated the capabilities of the implant by utilizing brain signals to edit and narrate videos on YouTube.

This demonstration showcased the potential of the technology to restore communication and functionality. The patient shared their experience through a video posted earlier this month.